UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 459

Sortiert nach

Gut microbiome and prostate cancer

International journal of urology, 2022-08, Vol.29 (8), p.793-798

2022

Link zum Volltext

Verfügbarkeit prüfen

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome

Cancers, 2023-02, Vol.15 (5), p.1375

2023

Link zum Volltext

Verfügbarkeit prüfen

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing

PloS one, 2015-05, Vol.10 (5), p.e0121891-e0121891

2015

Link zum Volltext

Verfügbarkeit prüfen

Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin

PloS one, 2014-04, Vol.9 (4), p.e94772

2014

Link zum Volltext

Verfügbarkeit prüfen

Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer

Human cell : official journal of Human Cell Research Society, 2020-07, Vol.33 (3), p.730-736

2020

Link zum Volltext

Verfügbarkeit prüfen

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

Cancer science, 2016-08, Vol.107 (8), p.1134-1140

2016

Link zum Volltext

Verfügbarkeit prüfen

Syndecan‐1, a new target molecule involved in progression of androgen‐independent prostate cancer

Cancer science, 2009-07, Vol.100 (7), p.1248-1254

2009

Link zum Volltext

Verfügbarkeit prüfen

Role of syndecan‐1 (CD138) in cell survival of human urothelial carcinoma

Cancer science, 2010-01, Vol.101 (1), p.155-160

2010

Link zum Volltext

Verfügbarkeit prüfen

Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis

Molecular oncology, 2022-04, Vol.16 (7), p.1493-1507

2022

Link zum Volltext

Verfügbarkeit prüfen

Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer

Cancer letters, 2015-01, Vol.356 (2), p.819-827

2015

Link zum Volltext

Verfügbarkeit prüfen

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (5), p.2053-2063

2010

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome Profiling and Metagenomic Analysis Help to Elucidate Interactions in an Inflammation-Associated Cancer Mouse Model

Cancers, 2021-07, Vol.13 (15), p.3683

2021

Link zum Volltext

Verfügbarkeit prüfen

Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis

Scientific reports, 2020-11, Vol.10 (1), p.19186-19186, Article 19186

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

BMC cancer, 2017-04, Vol.17 (1), p.281-281, Article 281

2017

Link zum Volltext

Verfügbarkeit prüfen

HOXA10 expression profiling in prostate cancer

The Prostate, 2019-04, Vol.79 (5), p.554-563

2019

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis

Frontiers in oncology, 2021-10, Vol.11, p.763468-763468

2021

Link zum Volltext

Verfügbarkeit prüfen

MEK inhibitors against MET-amplified non-small cell lung cancer

International journal of oncology, 2016-12, Vol.49 (6), p.2236-2244

2016

Link zum Volltext

Verfügbarkeit prüfen

Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period

Hepatology international, 2022-02, Vol.16 (1), p.135-147

2022

Link zum Volltext

Verfügbarkeit prüfen

Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC

Molecular cancer therapeutics, 2016-08, Vol.15 (8), p.1988-1997

2016

Link zum Volltext

Verfügbarkeit prüfen

Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer

Cancers, 2021-08, Vol.13 (16), p.3975

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer

Oncotarget, 2016-03, Vol.7 (13), p.15959-15976

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological and genetic differences between low‐grade and high‐grade colorectal mucinous adenocarcinomas

Cancer, 2015-12, Vol.121 (24), p.4359-4368

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration‐resistant prostate cancer

Cancer science, 2010-03, Vol.101 (3), p.601-608

2010

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer immunotherapy: where are we and where are we going?

Current opinion in urology, 2018-01, Vol.28 (1), p.15-24

2018

Link zum Volltext

Verfügbarkeit prüfen

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients

Translational andrology and urology, 2021-07, Vol.10 (7), p.2838-2847

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 459

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(406)
Mit Volltextzugriff
(426)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Gut microbiome and prostate cancer

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing

Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin

Chemopreventive effects of nanoparticle curcumin in a mouse model of Pten-deficient prostate cancer

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

Syndecan‐1, a new target molecule involved in progression of androgen‐independent prostate cancer

Role of syndecan‐1 (CD138) in cell survival of human urothelial carcinoma

Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis

Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer

FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth

Transcriptome Profiling and Metagenomic Analysis Help to Elucidate Interactions in an Inflammation-Associated Cancer Mouse Model

Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

HOXA10 expression profiling in prostate cancer

Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis

MEK inhibitors against MET-amplified non-small cell lung cancer

Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period

Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC

Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer

Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer

Clinicopathological and genetic differences between low‐grade and high‐grade colorectal mucinous adenocarcinomas

Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration‐resistant prostate cancer

Prostate cancer immunotherapy: where are we and where are we going?

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients

Suchergebnisse filtern